Gentian Diagnostics ASA (GENT.OL)

NOK 39.0

(0.0%)

Net Debt Summary of Gentian Diagnostics ASA

Gentian Diagnostics ASA's latest annual net debt in 2023 was -78.63 Million NOK , down -18.65% from previous year.
Gentian Diagnostics ASA's latest quarterly net debt in 2024 Q3 was -93.79 Million NOK , down -19.02% from previous quarter.
Gentian Diagnostics ASA reported annual net debt of -66.27 Million NOK in 2022, up 31.21% from previous year.
Gentian Diagnostics ASA reported annual net debt of -96.35 Million NOK in 2021, up 28.82% from previous year.
Gentian Diagnostics ASA reported quarterly net debt of -93.79 Million NOK for 2024 Q3, down -19.02% from previous quarter.
Gentian Diagnostics ASA reported quarterly net debt of -76.72 Million NOK for 2024 Q1, up 2.43% from previous quarter.

Annual Net Debt Chart of Gentian Diagnostics ASA (2023 - 2013)

Historical Annual Net Debt of Gentian Diagnostics ASA (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	-78.63 Million NOK	-18.65%
2022	-66.27 Million NOK	31.21%
2021	-96.35 Million NOK	28.82%
2020	-135.37 Million NOK	18.91%
2019	-166.94 Million NOK	15.52%
2018	-197.6 Million NOK	-36.41%
2017	-144.86 Million NOK	-94.85%
2016	-74.34 Million NOK	-55.14%
2015	-47.92 Million NOK	-1264.93%
2014	4.11 Million NOK	-49.63%
2013	8.16 Million NOK	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-73.24 Million NOK	4.53%
2024 Q3	-93.79 Million NOK	-19.02%
2024 Q1	-76.72 Million NOK	2.43%
2023 Q2	-69.71 Million NOK	-7.76%
2023 Q1	-64.69 Million NOK	2.38%
2023 Q4	-78.63 Million NOK	-18.47%
2023 FY	-78.63 Million NOK	-18.65%
2023 Q3	-66.37 Million NOK	4.79%
2022 Q3	-77.16 Million NOK	-2.42%
2022 Q4	-66.27 Million NOK	14.11%
2022 Q2	-75.34 Million NOK	8.56%
2022 FY	-66.27 Million NOK	31.21%
2022 Q1	-82.39 Million NOK	14.49%
2021 Q2	-116.48 Million NOK	3.85%
2021 FY	-96.35 Million NOK	28.82%
2021 Q1	-121.15 Million NOK	10.5%
2021 Q4	-96.35 Million NOK	12.46%
2021 Q3	-110.06 Million NOK	5.51%
2020 Q2	-154.5 Million NOK	0.34%
2020 FY	-135.37 Million NOK	18.91%
2020 Q3	-146.53 Million NOK	5.16%
2020 Q4	-135.37 Million NOK	7.62%
2020 Q1	-155.02 Million NOK	7.14%
2019 Q1	-184.41 Million NOK	6.68%
2019 Q3	-163.43 Million NOK	4.95%
2019 Q2	-171.95 Million NOK	6.76%
2019 FY	-166.94 Million NOK	15.52%
2019 Q4	-166.94 Million NOK	-2.15%
2018 Q4	-197.6 Million NOK	-2.65%
2018 Q2	-197.53 Million NOK	-44.32%
2018 Q1	-136.87 Million NOK	5.52%
2018 FY	-197.6 Million NOK	-36.41%
2018 Q3	-192.5 Million NOK	2.55%
2017 FY	-144.86 Million NOK	-94.85%
2017 Q2	-151.45 Million NOK	4.11%
2017 Q4	-144.86 Million NOK	0.75%
2017 Q3	-145.96 Million NOK	3.63%
2017 Q1	-157.94 Million NOK	-112.44%
2016 Q3	-56.13 Million NOK	0.0%
2016 FY	-74.34 Million NOK	-55.14%
2016 Q4	-74.34 Million NOK	-32.45%
2015 Q4	-47.92 Million NOK	0.0%
2015 FY	-47.92 Million NOK	-1264.93%
2014 FY	4.11 Million NOK	-49.63%
2013 FY	8.16 Million NOK	0.0%

Peer Net Debt Comparison of Gentian Diagnostics ASA

Name	Net Debt	Net Debt Difference
Lifecare AS	-41.89 Million NOK	-87.698%
Medistim ASA	-144.61 Million NOK	45.623%